Beyond FDA regulatory oversight, medical product companies must navigate a complex landscape of multiple agencies and non-governmental organizations, each with their own enforcement priorities and regulatory frameworks. Foley Hoag Advertising and Marketing Practice Chair, August Horvath will address this critical topic during the FDLI Introduction to Advertising and Promotion for Medical Products Conference. Drawing on his extensive experience in advertising law and regulatory compliance, August will explore the roles of key regulatory bodies including the DOJ, FTC, SEC, and HHS OIG, as well as industry watchdogs like the National Advertising Division and Better Business Bureau, while examining fundamental laws such as the Lanham Act, False Claims Act, Anti-Kickback Statute, Qui Tam actions, and SEC anti-fraud provisions. This session is designed for legal and compliance professionals, marketing teams, and executives who need to understand the full scope of regulatory oversight for medical device advertising and promotion, offering practical knowledge on navigating multi-agency compliance requirements and developing effective risk management strategies.